• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

12th Invest in ME International ME Conference 2017 registration is open

Jo Best

Senior Member
Messages
1,032
@trishrhymes @Invisible Woman @JaimeS you all reminded me of a comment on one of David Tuller's recent articles by a parent (hope it's not off-topic here as David is the IIMEC12 pre-conference dinner speaker). Specifically this -
I also asked Esther about the rituximab trial in Norway which I had read about in the New Scientist with real excitement - as my husband is on a similar immune-suppressant which has made a huge difference to his health, I could completely understand that this might be a breakthrough. In response Esther was completely dismissive of the trial itself, making very strong statements about the dodgy nature of the methodology of the investigators involved, and suggesting that this was the general view of the scientific community. How interesting to discover later, then, that very similar aspersions had been made about her own work.
Source - http://www.virology.ws/2016/11/21/t...new-fitnet-trial-for-kids/#comment-3015192110
The whole comment, for context -
I inadvertently joined Esther Crawley's Patient Advisory Group last year, not knowing anything about her or PACE, after my teenage daughter collapsed with ME. I had ME myself twenty years ago, and her father has Ankylosing Spondylitis, a rheumatic auto-immune disease. It has always struck me how very similar many of the symptoms are, including the fatigue, which has kept him off work for several years at a time during his working life, and the up-and-down nature of the illness. Although I'm not a medic, I am an academic, and I was interested to meet Esther; when she claimed that most children and young people got better within 6 months, I asked her if she checked how well they were in the months and years after that. She swept away my question by saying that she clearly didn't have the funding to contact people after the end of the study. I thought this odd. My daughter felt better after 6 months, but much, much worse after 8. She has now been housebound for 18 months, and too ill to continue her education. I also asked Esther about the rituximab trial in Norway which I had read about in the New Scientist with real excitement - as my husband is on a similar immune-suppressant which has made a huge difference to his health, I could completely understand that this might be a breakthrough. In response Esther was completely dismissive of the trial itself, making very strong statements about the dodgy nature of the methodology of the investigators involved, and suggesting that this was the general view of the scientific community. How interesting to discover later, then, that very similar aspersions had been made about her own work. As an academic under increasing pressures to get funding and grow my international reputation and evidence of 'impact', I can understand Esther's hard work to convince society of the effectiveness of her research through the media. I don't, however, forgive her for her ability to suspend her morals by dismissing all evidence which suggests that she is wrong. As Karl Popper pointed out, we should all be trying as hard as we can to disprove our hypotheses, as only then can we hope to prove them.
Source - http://www.virology.ws/2016/11/21/t...new-fitnet-trial-for-kids/#comment-3015192110
 

Jo Best

Senior Member
Messages
1,032
Sponsorship opportunities - http://investinme.eu/IIMEC12-sponsorship.shtml

Invest in ME Research is run by volunteers and all work is carried out for free. The charity does not receive government funding or huge donations from big institutions to run the conference. We therefore welcome support in enabling us to create a major international event which helps to make progress in researching and treating this disease.

We hope to attract to the conference professionals working in healthcare (GPs, nurses, paediatricians etc.), researchers, students, media personnel, politicians as well as people with ME, their carers and/or parents and ME support groups and charities.

To enable us to provide the best Conference possible we welcome donations or sponsorship from companies, organisations, support groups and individuals to make the International ME Conferences and Colloquiums a success.

We offer a number of opportunities to promote your organisation at our conference, including those listed below. To discuss further then please contact us.

In full here - http://investinme.eu/IIMEC12-sponsorship.shtml
 

Jo Best

Senior Member
Messages
1,032
Invest in ME Research is pleased to welcome back Professor Ian Charles to open the #IIMEC12 conference - http://investinme.eu/IIMEC12-news-170104.shtml

Professor Charles opened the 10th Invest in ME Research International Conference in London in 2015.

Professor Charles officially joined the Institute of Food Research in May as lead in the UK’s Centre for Food & Health programme, to be based at the Norwich Research Park.

He has over 30 years’ experience in academic and commercial research and was a founding member of The Wolfson Institute for Biomedical Research at University College London, one the UK’s first institutes of translational medicine.

In full here - http://investinme.eu/IIMEC12-news-170104.shtml
 
Messages
28
http://www.investinme.eu/IIMEC12-news-170202.shtml

CDC Participating in Colloquium and Conference

INTERNATIONAL RESEARCH COLLABORATION FOR ME

Dr Elizabeth Unger from CDC Attending #BRMEC7 / #IIMEC12

The objective with Invest in ME Research’s Colloquiums are to encourage and facilitate collaboration and sharing of knowledge between high-quality biomedical researchers around the world.

We also want to enable patients and carers and clinicians and healthcare staff – and the media – to become more educated about this disease and to hear of this research, mingle with each other and learn more of ME and its effects. This is why we hold the public conference following the colloquium.

The need is for better education, more funding for biomedical research and collaboration between researchers

The Colloquium has proved very successful and multiple collaborations have been created, new research has been initiated and, we dare to say, far more communications have been made between researchers across international boundaries.

Coming together, keeping together, ....and now working together!

Last year we had the USA National Institues for Health (NIH) represented and we are very pleased and honoured to have Dr Vicky Whittemore again returning this year to make keynote speeches at both Colloquium and Conference events.

BethUnger.jpg




Dr Beth Unger
We are are now enormously pleased to announce that the USA Centers for Disease Control and Prevention (CDC) will also be represented at both Colloquium and Conference. Dr Beth Unger has accepted our invitation to both BRMEC7 and IIMEC12.

This means we will have representation from the major Centres around the world, including the UK Centre of Excellence in Norwich Research Park, from major Australian, US and European institutes and from major agencies such as NIH, CDC – and some others that we are awaiting to announce officially.

Elizabeth Unger PhD, MD Chief, Chronic Viral Diseases Branch Division of High-Consequence Pathogens and Pathology National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA

Dr. Unger received an undergraduate degree in Chemistry at Lebanon Valley College, Annville, PA. She then earned her PhD and MD in the Division of Biologic Sciences at the University of Chicago where she also began a residency in pathology. Her residency and fellowship was completed at Pennsylvania State University Medical Center.

She is co-author of 142 peer-reviewed publications and 24 book chapters and serves on the editorial board of six scientific journals. In 2008, for her HPV research accomplishments, she received the Health and Human Services (HHS) Career Achievement Award.

During this time, Dr. Unger developed a practical method of colorimetic in situ hybridization. This work led to interest in tissue localization of HPV and ultimately to her initial appointment to CDC in 1997 to pursue molecular pathology of HPV and CFS.

Dr. Unger is on the editorial boards of Journal of Molecular Diagnostics, Diagnostic Medical Pathology and the Journal of Histochemistry and Cytochemistry and she has served on boards, committees and working groups of organizations such as World Health Organization, Food and Drug Administration, Gates Foundation Global Health Program, American Social Health Association and College of American Pathologists.

At the CDC she was a member of the team that pioneered the use of gene expression in immune cells. She also helped establish the CDC’s partnership with the National Cancer Institute for the Early Detection Research Network. In 2008 she received the Health and Human Services (HHS) Career Achievement Award for her work with human papilloma virus.

Further Links

Last Update 11/02/2017

Invest in ME Research - Energising Research into ME
 

Jo Best

Senior Member
Messages
1,032
"Norges Helsedirektoratet (Norwegian Directorate of Health) will participate in the #BRMEC7 Colloquium and #IIMEC12 Conference events in London". Source - https://www.facebook.com/events/1510153035676999/

Norwegian Prime Minister mentioned the conference in her blog - https://erna.no/2017/02/09/disse-pasientene-fortjener-a-bli-tatt-pa-alvor/

Nine Norwegian researchers will participate in the conference/colloquium.

Norges ME Forening is a sponsor of the conference.

News page - http://www.investinme.eu/IIMEC12-news.shtml
 

Jo Best

Senior Member
Messages
1,032
Looks like the speakers are all lined up now - http://investinme.eu/IIMEC12.shtml#agenda

Dr Ian Gibson Welcome to IIMEC12

Ian Charles Opening Keynote Speech: UK Centre of Excellence

Dr Vicky Whittemore Keynote Speech: NIH Research into ME

Professor Sonya Marshall-Gradisnik

Dr Jo Cambridge / Fane Mensah

Professor Simon Carding

Jakob Theorell

IiMER funded students

Professor Mady Hornig

Professor Olav Mella/Dr Øystein Fluge

Professor Warren Tate

Professor Ron Davis

Dr Ian Gibson Plenary Session

More detail on the speakers in the news items - http://investinme.eu/IIMEC12-news.shtml
 

Mark

Senior Member
Messages
5,238
Location
Sofa, UK
I've booked in, who else is going?
I regret to report that neither I nor Kina will be able to make it to the conference this year. :(

So I am hoping that one or more members who are attending may be able to cover the conference for Phoenix Rising, by tweeting and/or writing one or more articles about the conference. We are able to pay for travel expenses, accommodation and conference fees, for anyone who's able to do this. Obviously the budget isn't unlimited, but if a few members who are attending want to combine forces and tweet a few sessions each, for example, we could contribute towards the costs of attending for several people.

Anyone who's interested in this, please start a conversation with me and I'll be happy to discuss our options and to help plan and co-ordinate our coverage.